The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large-scale global cohort study

Khalaf Kridin*, Noor Mruwat, Diamant Thaci, Ralf J. Ludwig

*Corresponding author for this work
Original languageEnglish
JournalJournal of the European Academy of Dermatology and Venereology
Issue number5
Pages (from-to)e683-e685
Publication statusPublished - 05.2023

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)
  • Centers: Center for Research on Inflammation of the Skin (CRIS)

DFG Research Classification Scheme

  • 204-05 Immunology
  • 205-19 Dermatology

Cite this